Search Results 221-230 of 18544 for Relapse

  1. A Study of Androgen Annihilation in High-Risk Biochemically Relapsed Prostate Cancer - Mayo Clinic

    A Study of Androgen Annihilation in High-Risk Biochemically Relapsed Prostate Cancer. Print details. Share; Facebook · Twitter. Overview; Participation ...

  2. Addiction Services - Outpatient treatment for addiction - Mayo Clinic

    Educational and relapse-prevention group sessions. Process group psychotherapy sessions. Individual counseling. Friday family day (every other Friday) ...

  3. Medical Research & Education - Mayo Clinic News Network

    ROCHESTER, Minn. — Mayo Clinic researchers have discovered a key reason some cancer patients relapse after receiving chimeric antigen receptor T-cell therapy, ...

  4. First in Human Study of KO-539 to Treat Relapsed or Refractory Acute Myeloid Leukemia - Mayo Clinic

    The purpose of this study is to determine the maximum tolerated dose (MTD) of KO-539, a menin-MLL(KMT2A) inhibitor, in patients with refractory or relapsed ...

  5. Medical Research & Education - Mayo Clinic News Network

    ROCHESTER, Minn. — Mayo Clinic researchers have discovered a key reason some cancer patients relapse after receiving chimeric antigen receptor T-cell therapy, ...

  6. Aurora A Kinase Inhibitor MLN8237 and Bortezomib in Treating Patients With Relapsed or Refractory Multiple Myeloma - Mayo Clinic

    Aurora A Kinase Inhibitor MLN8237 and Bortezomib in Treating Patients With Relapsed or Refractory Multiple Myeloma · Overview · Participation eligibility.

  7. Phase 1 Study of Intradermal LV305 in Patients With Locally Advanced, Relapsed or Metastatic Cancer Expressing NY-ESO-1 - Mayo Clinic

    Phase 1 Study of Intradermal LV305 in Patients With Locally Advanced, Relapsed or Metastatic Cancer Expressing NY-ESO-1 ... Inadequate response,relapse, and/or ...

  8. Diffuse large B-cell lymphoma - Symptoms and causes - Mayo Clinic

    This is called a relapse. Sometimes the relapse happens years later. Some people may have multiple relapses. By Mayo Clinic Staff.

  9. Lenalidomide Plus Rituximab Followed by Lenalidomide Versus Rituximab Maintenance for Relapsed/Refractory Follicular, Marginal Zone or Mantle Cell Lymphoma. - Mayo Clinic

    Lenalidomide Plus Rituximab Followed by Lenalidomide Versus Rituximab Maintenance for Relapsed/Refractory Follicular, Marginal Zone or Mantle Cell Lymphoma.

  10. A Study to Evaluate the Effectiveness and Safety of bb2121 in Subjects with Relapsed and Refractory Multiple Myeloma and in Subjects with Clinical High-Risk Multiple Myeloma - Mayo Clinic

    ... relapse. The cohorts will start in parallel and independently. Participation eligibility. Participant eligibility includes age, gender, type and stage of ...